N
MRNA icon

Nuveen’s Moderna MRNA Stock Holding History

Nuveen’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-30,900
Closed -$5K – 3401
2022
Q1 		$5K Buy
+30,900
New +$5.2M ﹤0.01% 3327
2021
Q4 		– Sell
-20,600
Closed -$8K – 3380
2021
Q3 		$8K Sell
20,600
-6,800
-25% -$2.51M ﹤0.01% 3337
2021
Q2 		$6K Buy
+27,400
New +$4.9M ﹤0.01% 3299

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Nuveen's MRNA Position: Q1 2026 in Review

Nuveen reduced its Moderna (MRNA) stake by 4.1% in Q1 2026, selling an estimated $2.17M and leaving 1,078,194 shares worth $54.8M. The position accounts for 0.01% of the portfolio, ranked #604.

Nuveen first reported a position in MRNA in Q2 2019 and has held it in 28 quarters since. The position peaked at $490M in Q3 2021. 723 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • Nuveen held 1,078,194 shares of Moderna worth $54.8M as of Q1 2026.
  • Nuveen sold 46,508 Moderna shares in Q1 2026, an estimated $2.17M.
  • Moderna made up 0.01% of Nuveen's portfolio in Q1 2026, its #604 holding.
  • Nuveen first reported a position in Moderna in Q2 2019 and has held it in 28 quarters since.
  • Nuveen's Moderna position peaked at $490M in Q3 2021.
  • 723 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.